Gestational Diabetes Mellitus, commonly known as GDM, is defined as carbohydrate intolerance that is first recognized during pregnancy. During a normal pregnancy, profound hormonal and metabolic shifts occur to ensure the growing fetus receives a continuous supply of glucose. Placental hormones such as human placental lactogen, progesterone, and cortisol create a state of insulin resistance, particularly in the second and third trimesters. In a healthy pregnant woman, the pancreas compensates by increasing insulin production. When the maternal pancreatic beta-cells fail to meet this increased demand, blood glucose levels rise, resulting in gestational diabetes.
Midwives must identify clients at risk for GDM during the booking visit to ensure timely screening. Not every pregnant woman carries the same level of vulnerability.
Implementing practical screening protocols in busy Nigerian antenatal clinics requires balancing clinical accuracy with resource availability. Universal screening is ideal, but where laboratory support is constrained, risk-factor-based screening helps prioritize high-risk clients. Initial booking investigations usually include a random blood sugar or fasting blood sugar. Clients with risk factors who test negative early in pregnancy should undergo a definitive diagnostic test between 24 and 28 weeks of gestation, when placental hormone antagonism peaks.
The Oral Glucose Tolerance Test (OGTT) remains the gold standard for diagnosing gestational diabetes. The standard procedure requires the client to fast overnight for at least eight hours. A fasting venous blood sample is drawn, after which the client drinks a solution containing 75 grams of anhydrous glucose dissolved in water. Further venous blood samples are collected at one hour and two hours post-load. Elevated values at any single time point—fasting, one-hour, or two-hour—are sufficient to confirm gestational diabetes, guiding immediate multidisciplinary management.
Medical nutrition therapy forms the bedrock of GDM treatment. Midwives work alongside dietitians to counsel clients on balanced meal planning, emphasizing complex carbohydrates with low glycemic indices, lean proteins, and high fiber. Total caloric restriction is avoided to prevent maternal ketosis, which can harm the fetus. Regular moderate physical activity, such as brisk walking for thirty minutes post-meal, enhances peripheral glucose uptake. Clients learn to perform self-monitoring of blood glucose (SMBG) using a glucometer to track fasting and postprandial levels daily.
When diet and lifestyle modifications fail to maintain target blood glucose ranges—usually defined as fasting below 5.3 mmol/L and two-hour postprandial below 6.7 mmol/L—pharmacological therapy is introduced. While insulin remains the traditional gold standard because it does not cross the placenta in significant amounts, oral agents like metformin and glyburide are increasingly utilized in clinical practice. Insulin regimens often combine intermediate-acting and short-acting preparations to match physiological mealtime spikes and basal requirements.
Uncontrolled maternal hyperglycemia exposes the fetus to excess glucose, triggering fetal hyperinsulinemia. This cascade leads to several complications, including macrosomia (large for gestational age), shoulder dystocia, neonatal hypoglycemia, and polyhydramnios. To protect the fetus, enhanced surveillance is implemented in the third trimester. Serial ultrasound scans monitor fetal growth and amniotic fluid volume, while biophysical profiles or non-stress tests assess fetal well-being from 32 weeks onward in poorly controlled or insulin-requiring cases.
Intrapartum management focuses on preventing birth trauma and neonatal complications. Continuous fetal heart rate monitoring is standard during labor. Blood glucose levels are monitored hourly, and intravenous insulin with dextrose infusions may be used to maintain tight maternal glycemic control during the active phase of labor. Following delivery, the placenta is expelled, causing an immediate drop in placental hormone antagonism; thus, insulin requirements plummet. Routine postpartum care includes checking fasting blood glucose or performing a 75-gram OGTT at six weeks postpartum to confirm the resolution of GDM and screen for lingering type 2 diabetes.